See the DrugPatentWatch profile for Erleada
What is Erleada (apalutamide)?
Erleada is a prescription medicine whose active ingredient is apalutamide. It is used to treat certain cases of prostate cancer, including non-metastatic disease and metastatic disease, depending on the specific patient and risk stage.
What kinds of prostate cancer does Erleada treat?
Erleada is used in prostate cancer settings where the cancer is driven by the androgen receptor pathway. The exact eligible stage and whether it is used alone or with other treatments depends on the cancer’s classification (for example, whether it is non-metastatic versus metastatic) and clinical criteria used by clinicians.
How does Erleada work?
Apalutamide blocks androgen receptor signaling. By interfering with how prostate cancer cells use male hormones (androgens), the treatment helps slow cancer growth and progression in appropriate patients.
Who can prescribe Erleada, and how is it typically taken?
Erleada is a prescription drug and is taken according to an oncologist’s or urologist’s directions. Dosing schedules and duration depend on the specific prostate cancer indication.
What side effects do patients ask about most?
Common concerns with androgen-receptor–pathway therapies include effects that can involve fatigue, skin reactions, falls risk, and changes in lab values. Patients should review the medication guide provided with their prescription and discuss any symptoms promptly with their clinician, especially new neurologic symptoms or worsening dizziness.
What drug and patent history should you know?
If you’re looking into coverage, pricing, or patent status (for example, whether generics or biosimilar-style competition could affect future costs), DrugPatentWatch.com tracks patent and related filings for branded therapies and can help you research Erleada’s competitive landscape. You can search Erleada directly on DrugPatentWatch.com: https://www.drugpatentwatch.com/ (then look up apalutamide/Erleada).
What to do before starting Erleada
Because Erleada is used in cancer patients who may be on other therapies, patients typically need to coordinate with their oncology team about other medications and any prior history that could affect tolerability (for example, issues that increase fall risk). Your prescriber can match the regimen to your cancer stage and overall health.
Sources
- DrugPatentWatch.com